Supplemental Guarantor Information - Condensed Consolidating Statements of Cash Flows (Details) - USD ($) | 3 Months Ended |
Mar. 31, 2016 | Mar. 31, 2015 |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | $ 66,000,000 | $ 6,300,000 |
Capital expenditures | (62,400,000) | (57,900,000) |
Dividends received from CyrusOne | 2,100,000 | 6,000,000 |
Other investing activities | (100,000) | (100,000) |
Net cash used in investing activities | (60,400,000) | (52,000,000) |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 28,900,000 | 7,500,000 |
Repayment of debt | (30,900,000) | (3,300,000) |
Other financing activities | (500,000) | (400,000) |
Net cash (used in) provided by financing activities | (5,100,000) | 1,200,000 |
Increase (decrease) in cash and cash equivalents | 500,000 | (44,500,000) |
Cash and cash equivalents at beginning of period | 7,400,000 | 57,900,000 |
Cash and cash equivalents at end of period | 7,900,000 | 13,400,000 |
Notes guaranteed by parent [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | 66,000,000 | 6,300,000 |
Capital expenditures | (62,400,000) | (57,900,000) |
Dividends received from CyrusOne | 2,100,000 | 6,000,000 |
Distributions received from subsidiaries | 0 | 0 |
Funding between Parent and subsidiaries, net | 0 | 0 |
Other investing activities | (100,000) | (100,000) |
Net cash used in investing activities | (60,400,000) | (52,000,000) |
Funding between Parent and subsidiaries, net | 0 | 0 |
Distributions paid to Parent | 0 | 0 |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 28,900,000 | 7,500,000 |
Repayment of debt | (30,900,000) | (3,300,000) |
Other financing activities | (3,100,000) | (3,000,000) |
Net cash (used in) provided by financing activities | (5,100,000) | 1,200,000 |
Increase (decrease) in cash and cash equivalents | 500,000 | (44,500,000) |
Cash and cash equivalents at beginning of period | 7,400,000 | 57,900,000 |
Cash and cash equivalents at end of period | 7,900,000 | 13,400,000 |
Notes guaranteed by parent [Member] | Parent Company [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | (21,700,000) | (23,500,000) |
Capital expenditures | (100,000) | 0 |
Dividends received from CyrusOne | 0 | 0 |
Distributions received from subsidiaries | 2,900,000 | 2,700,000 |
Funding between Parent and subsidiaries, net | 0 | 0 |
Other investing activities | (100,000) | (100,000) |
Net cash used in investing activities | 2,700,000 | 2,600,000 |
Funding between Parent and subsidiaries, net | 24,800,000 | (20,400,000) |
Distributions paid to Parent | 0 | 0 |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 0 | 0 |
Repayment of debt | (1,400,000) | (1,300,000) |
Other financing activities | (3,100,000) | (3,000,000) |
Net cash (used in) provided by financing activities | 20,300,000 | (24,700,000) |
Increase (decrease) in cash and cash equivalents | 1,300,000 | (45,600,000) |
Cash and cash equivalents at beginning of period | 4,600,000 | 56,200,000 |
Cash and cash equivalents at end of period | 5,900,000 | 10,600,000 |
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | 63,600,000 | 35,700,000 |
Capital expenditures | (55,800,000) | (51,800,000) |
Dividends received from CyrusOne | 0 | 0 |
Distributions received from subsidiaries | 0 | 0 |
Funding between Parent and subsidiaries, net | 20,700,000 | 17,300,000 |
Other investing activities | 0 | 0 |
Net cash used in investing activities | (35,100,000) | (34,500,000) |
Funding between Parent and subsidiaries, net | 0 | 0 |
Distributions paid to Parent | 0 | 0 |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 0 | 0 |
Repayment of debt | (28,400,000) | (1,000,000) |
Other financing activities | 0 | 0 |
Net cash (used in) provided by financing activities | (28,400,000) | (1,000,000) |
Increase (decrease) in cash and cash equivalents | 100,000 | 200,000 |
Cash and cash equivalents at beginning of period | 1,000,000 | 1,000,000 |
Cash and cash equivalents at end of period | 1,100,000 | 1,200,000 |
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | 24,100,000 | (5,900,000) |
Capital expenditures | (6,500,000) | (6,100,000) |
Dividends received from CyrusOne | 2,100,000 | 6,000,000 |
Distributions received from subsidiaries | 0 | 0 |
Funding between Parent and subsidiaries, net | 2,900,000 | 10,900,000 |
Other investing activities | 0 | 0 |
Net cash used in investing activities | (1,500,000) | 10,800,000 |
Funding between Parent and subsidiaries, net | (48,400,000) | (7,800,000) |
Distributions paid to Parent | (2,900,000) | (2,700,000) |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 28,900,000 | 7,500,000 |
Repayment of debt | (1,100,000) | (1,000,000) |
Other financing activities | 0 | 0 |
Net cash (used in) provided by financing activities | (23,500,000) | (4,000,000) |
Increase (decrease) in cash and cash equivalents | (900,000) | 900,000 |
Cash and cash equivalents at beginning of period | 1,800,000 | 700,000 |
Cash and cash equivalents at end of period | 900,000 | 1,600,000 |
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | 0 | 0 |
Capital expenditures | 0 | 0 |
Dividends received from CyrusOne | 0 | 0 |
Distributions received from subsidiaries | (2,900,000) | (2,700,000) |
Funding between Parent and subsidiaries, net | (23,600,000) | (28,200,000) |
Other investing activities | 0 | 0 |
Net cash used in investing activities | (26,500,000) | (30,900,000) |
Funding between Parent and subsidiaries, net | 23,600,000 | 28,200,000 |
Distributions paid to Parent | 2,900,000 | 2,700,000 |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 0 | 0 |
Repayment of debt | 0 | 0 |
Other financing activities | 0 | 0 |
Net cash (used in) provided by financing activities | 26,500,000 | 30,900,000 |
Increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 |
Notes guaranteed by subsidiaries [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | 66,000,000 | 6,300,000 |
Capital expenditures | (62,400,000) | (57,900,000) |
Dividends received from CyrusOne | 2,100,000 | 6,000,000 |
Distributions received from subsidiaries | 0 | 0 |
Funding between Parent and subsidiaries, net | 0 | 0 |
Other investing activities | (100,000) | (100,000) |
Net cash used in investing activities | (60,400,000) | (52,000,000) |
Funding between Parent and subsidiaries, net | 0 | 0 |
Distributions paid to Parent | 0 | 0 |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 28,900,000 | 7,500,000 |
Repayment of debt | (30,900,000) | (3,300,000) |
Other financing activities | (3,100,000) | (3,000,000) |
Net cash (used in) provided by financing activities | (5,100,000) | 1,200,000 |
Increase (decrease) in cash and cash equivalents | 500,000 | (44,500,000) |
Cash and cash equivalents at beginning of period | 7,400,000 | 57,900,000 |
Cash and cash equivalents at end of period | 7,900,000 | 13,400,000 |
Notes guaranteed by subsidiaries [Member] | Parent Company [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | (21,700,000) | (23,500,000) |
Capital expenditures | (100,000) | 0 |
Dividends received from CyrusOne | 0 | 0 |
Distributions received from subsidiaries | 2,900,000 | 2,700,000 |
Funding between Parent and subsidiaries, net | 0 | 0 |
Other investing activities | (100,000) | (100,000) |
Net cash used in investing activities | 2,700,000 | 2,600,000 |
Funding between Parent and subsidiaries, net | 24,800,000 | (20,400,000) |
Distributions paid to Parent | 0 | 0 |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 0 | 0 |
Repayment of debt | (1,400,000) | (1,300,000) |
Other financing activities | (3,100,000) | (3,000,000) |
Net cash (used in) provided by financing activities | 20,300,000 | (24,700,000) |
Increase (decrease) in cash and cash equivalents | 1,300,000 | (45,600,000) |
Cash and cash equivalents at beginning of period | 4,600,000 | 56,200,000 |
Cash and cash equivalents at end of period | 5,900,000 | 10,600,000 |
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | (8,200,000) | (19,200,000) |
Capital expenditures | (6,500,000) | (6,100,000) |
Dividends received from CyrusOne | 2,100,000 | 6,000,000 |
Distributions received from subsidiaries | 0 | 0 |
Funding between Parent and subsidiaries, net | 13,500,000 | 20,400,000 |
Other investing activities | 0 | 0 |
Net cash used in investing activities | 9,100,000 | 20,300,000 |
Funding between Parent and subsidiaries, net | 0 | 0 |
Distributions paid to Parent | 0 | 0 |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 0 | 0 |
Repayment of debt | (1,100,000) | (1,000,000) |
Other financing activities | 0 | 0 |
Net cash (used in) provided by financing activities | (1,100,000) | (1,000,000) |
Increase (decrease) in cash and cash equivalents | (200,000) | 100,000 |
Cash and cash equivalents at beginning of period | 400,000 | 200,000 |
Cash and cash equivalents at end of period | 200,000 | 300,000 |
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | 95,900,000 | 49,000,000 |
Capital expenditures | (55,800,000) | (51,800,000) |
Dividends received from CyrusOne | 0 | 0 |
Distributions received from subsidiaries | 0 | 0 |
Funding between Parent and subsidiaries, net | 0 | 7,200,000 |
Other investing activities | 0 | 0 |
Net cash used in investing activities | (55,800,000) | (44,600,000) |
Funding between Parent and subsidiaries, net | (38,300,000) | (7,200,000) |
Distributions paid to Parent | (2,900,000) | (2,700,000) |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 28,900,000 | 7,500,000 |
Repayment of debt | (28,400,000) | (1,000,000) |
Other financing activities | 0 | 0 |
Net cash (used in) provided by financing activities | (40,700,000) | (3,400,000) |
Increase (decrease) in cash and cash equivalents | (600,000) | 1,000,000 |
Cash and cash equivalents at beginning of period | 2,400,000 | 1,500,000 |
Cash and cash equivalents at end of period | 1,800,000 | 2,500,000 |
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member] | | |
Condensed Consolidating Statements of Cash Flows | | |
Cash flows provided by (used in) operating activities | 0 | 0 |
Capital expenditures | 0 | 0 |
Dividends received from CyrusOne | 0 | 0 |
Distributions received from subsidiaries | (2,900,000) | (2,700,000) |
Funding between Parent and subsidiaries, net | (13,500,000) | (27,600,000) |
Other investing activities | 0 | 0 |
Net cash used in investing activities | (16,400,000) | (30,300,000) |
Funding between Parent and subsidiaries, net | 13,500,000 | 27,600,000 |
Distributions paid to Parent | 2,900,000 | 2,700,000 |
Net increase (decrease) in corporate credit and receivables facilities with initial maturities less than 90 days | 0 | 0 |
Repayment of debt | 0 | 0 |
Other financing activities | 0 | 0 |
Net cash (used in) provided by financing activities | 16,400,000 | 30,300,000 |
Increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | $ 0 | $ 0 |